DNTH
Dianthus Therapeutics Inc.
$42.13
+$0.50(+1.20%)
56
Overall
60
Value
75
Tech
34
Quality
Market Cap
$1.53B
Volume
520.20K
52W Range
$13.37 - $45.46
Target Price
$64.45
EPS Estimates Overview
| Current Quarter | $-0.97 | Next Quarter | $-0.88 |
| Current Year | $-3.72 | Next Year | $-3.73 |
| QoQ Growth | +9.3% | YoY Growth | -0.3% |
| 3Y EPS CAGR | +50.2% | Target Price | $64.45 |
| Consensus | Buy | Upside | +53.0% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DNTH | $42.13 | +1.2% | 520.20K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Dianthus Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW